Device
SIR-Spheres microspheres
SIR-Spheres microspheres is a medical device with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)
Trials by Status
completed250%
terminated125%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Low-dose Y90 Treatment Planning for HCC
NCT04172714
terminatednot_applicable
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
NCT00503867
completedphase_3
FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer
NCT01721954
withdrawnphase_2
FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
NCT00735241
Clinical Trials (4)
Showing 4 of 4 trials
NCT04172714Not Applicable
Low-dose Y90 Treatment Planning for HCC
NCT00503867Not Applicable
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
NCT01721954Phase 3
FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer
NCT00735241Phase 2
FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4